Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 25058872)

1.

Structural characterization of the C3 domain of cardiac myosin binding protein C and its hypertrophic cardiomyopathy-related R502W mutant.

Zhang XL, De S, McIntosh LP, Paetzel M.

Biochemistry. 2014 Aug 19;53(32):5332-42. doi: 10.1021/bi500784g. Epub 2014 Aug 7.

PMID:
25058872
2.

A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.

Kuster DW, Govindan S, Springer TI, Martin JL, Finley NL, Sadayappan S.

J Biol Chem. 2015 Feb 27;290(9):5855-67. doi: 10.1074/jbc.M114.607911. Epub 2015 Jan 12.

PMID:
25583989
3.

COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.

Flavigny J, Souchet M, S├ębillon P, Berrebi-Bertrand I, Hainque B, Mallet A, Bril A, Schwartz K, Carrier L.

J Mol Biol. 1999 Nov 26;294(2):443-56.

PMID:
10610770
4.

E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.

De Lange WJ, Grimes AC, Hegge LF, Spring AM, Brost TM, Ralphe JC.

J Gen Physiol. 2013 Sep;142(3):241-55. doi: 10.1085/jgp.201311018.

5.

Molecular modeling of disease causing mutations in domain C1 of cMyBP-C.

Gajendrarao P, Krishnamoorthy N, Kassem HSh, Moharem-Elgamal S, Cecchi F, Olivotto I, Yacoub MH.

PLoS One. 2013;8(3):e59206. doi: 10.1371/journal.pone.0059206. Epub 2013 Mar 19.

6.
7.

Crystal structure of the C1 domain of cardiac myosin binding protein-C: implications for hypertrophic cardiomyopathy.

Govada L, Carpenter L, da Fonseca PC, Helliwell JR, Rizkallah P, Flashman E, Chayen NE, Redwood C, Squire JM.

J Mol Biol. 2008 Apr 25;378(2):387-97. doi: 10.1016/j.jmb.2008.02.044. Epub 2008 Mar 4.

PMID:
18374358
8.

In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament.

Harris SP, Lyons RG, Bezold KL.

Circ Res. 2011 Mar 18;108(6):751-64. doi: 10.1161/CIRCRESAHA.110.231670. Review.

10.

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities.

Schlossarek S, Mearini G, Carrier L.

J Mol Cell Cardiol. 2011 Apr;50(4):613-20. doi: 10.1016/j.yjmcc.2011.01.014. Epub 2011 Feb 1. Review.

PMID:
21291890
11.

MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation.

Kuster DW, Sadayappan S.

Pflugers Arch. 2014 Feb;466(2):207-13. doi: 10.1007/s00424-013-1417-7. Epub 2013 Dec 11. Review.

12.

A gain-of-function mutation in the M-domain of cardiac myosin-binding protein-C increases binding to actin.

Bezold KL, Shaffer JF, Khosa JK, Hoye ER, Harris SP.

J Biol Chem. 2013 Jul 26;288(30):21496-505. doi: 10.1074/jbc.M113.474346. Epub 2013 Jun 19.

13.

Axial distribution of myosin binding protein-C is unaffected by mutations in human cardiac and skeletal muscle.

Vydyanath A, Gurnett CA, Marston S, Luther PK.

J Muscle Res Cell Motil. 2012 May;33(1):61-74. doi: 10.1007/s10974-012-9286-9. Epub 2012 Mar 14.

15.

Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.

Meyer T, Pankuweit S, Richter A, Maisch B, Ruppert V.

Gene. 2013 Sep 15;527(1):416-20. doi: 10.1016/j.gene.2013.06.025. Epub 2013 Jun 29.

PMID:
23816408
16.

Functional and spectroscopic studies of a familial hypertrophic cardiomyopathy mutation in Motif X of cardiac myosin binding protein-C.

Brown LJ, Singh L, Sale KL, Yu B, Trent R, Fajer PG, Hambly BD.

Eur Biophys J. 2002 Sep;31(5):400-8. Epub 2002 Jun 25.

PMID:
12202917
17.

Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships.

Sequeira V, Witjas-Paalberends ER, Kuster DW, van der Velden J.

Pflugers Arch. 2014 Feb;466(2):201-6. doi: 10.1007/s00424-013-1400-3. Epub 2013 Nov 17. Review.

PMID:
24240729
18.

Structure, sarcomeric organization, and thin filament binding of cardiac myosin-binding protein-C.

Craig R, Lee KH, Mun JY, Torre I, Luther PK.

Pflugers Arch. 2014 Mar;466(3):425-31. doi: 10.1007/s00424-013-1426-6. Epub 2014 Jan 11. Review.

19.

Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations.

Moolman-Smook J, Flashman E, de Lange W, Li Z, Corfield V, Redwood C, Watkins H.

Circ Res. 2002 Oct 18;91(8):704-11.

20.

Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function.

van Dijk SJ, Paalberends ER, Najafi A, Michels M, Sadayappan S, Carrier L, Boontje NM, Kuster DW, van Slegtenhorst M, Dooijes D, dos Remedios C, ten Cate FJ, Stienen GJ, van der Velden J.

Circ Heart Fail. 2012 Jan;5(1):36-46. doi: 10.1161/CIRCHEARTFAILURE.111.963702. Epub 2011 Dec 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk